NCT05817461View on ClinicalTrials.gov

An ADME Study of [14C]AZD0780 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

June 6, 2023

Study Completion Date

June 6, 2023

Conditions

Cardiovascular Diseases

Interventions

DRUG

AZD0780 tablet

oral, fasted

DRUG

[14C]AZD0780 Solution for Infusion

intravenous

DRUG

[14C]AZD0780 Oral Solution

oral, fasted

Trial Locations (1)

NG11 6JS

Research Site, Ruddington

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Quotient Sciences

INDUSTRY

lead

AstraZeneca

INDUSTRY